By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Abbott today announced the expansion of an agreement with GlaxoSmithKline Biologicals for the development of an additional companion diagnostic test for GSK's cancer immunotherapy research program.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

David Dobbs writes at Buzzfeed that genomics has delivered little on its promises.

In PNAS this week: co-evolutionary signatures of insect hosts and bacterial symbionts, distinct transcript isoforms of high-grade ovarian cancer, and more.

Adam Rutherford discusses genetic genealogy at the Guardian.

Portions of the US 21st Century Cures Act are raising some safety concerns.